Patent details

EP3400292 Title: USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER

  • Data
  • Documents

Basic Information

Publication number:
EP3400292
PCT Application Number:
GB2017050039
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177003860
PCT Publication Number:
WO2017118867
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER
French Title of Invention:
UTILISATION D'UN VIRUS ONCOLYTIQUE POUR TRAITER LE CANCER
German Title of Invention:
VERWENDUNG EINES ONKOLYTISCHES VIRUS ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
09/01/2017
Grant date:
26/08/2020
EP Publication Date:
14/11/2018
PCT Publication Date:
13/07/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/08/2020
EP B1 Publication Date:
26/08/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/01/2021
Expiration date:
09/01/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/08/2020
 
 

Name:
Replimune Limited
Address:
69 Innovation Drive Milton Park, Abingdon, Oxfordshire OX14 4RQ, United Kingdom (GB)

Inventor

Name:
COFFIN, Robert
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201600382
Priority Date:
08/01/2016
Priority Country:
United Kingdom (GB)

2

Priority Number:
201600381
Priority Date:
08/01/2016
Priority Country:
United Kingdom (GB)

3

Priority Number:
201600380
Priority Date:
08/01/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
C12N 7/00;

Publication

European Patent Bulletin

Issue number:
202035
Publication date:
26/08/2020
Description:
Grant (B1)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: